Dexlansoprazole ER Pellets
Request a Quote

Dexlansoprazole ER Pellets

( Sustained Release  |  Enteric Coated  |  Instant Release )
( Multiple-Unit Pellet System )

Dexlansoprazole Pellet 17%, 20%, 22.5% DDR

Available percentage : 17%, 20%, 22.5% DDR

Physical form and appearance Spherical pellets
Physical state solid
Form Pellets
Molecular Weight 369.4 g/mol
Molecular formula C16H14F3N3O2S
Identification Complies by HPLC
Loss on Drying NMT 5%
Mesh size 14-20#, 30-60#
Storage Preserve in well-closed containers.
Store at room temperature.
Indication proton pump inhibitors
Cas registry No 138530-94-6
IUPAC name 2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

We supply Dexlansoprazole in pellets form and granules form. Our Dexlansoprazole Pellets can be used in a variety of Pharmaceutical applications like It can be used in tablets and capsules.

We also offer Sustained Release(SR) / Immediate Release (IR) and Enteric Coated (EC) Dexlansoprazole Pellets.

Umang pharmatech has the capability to manufacture Dexlansoprazole Pellets of various particle sizes.

See Products by Category